|
Volumn 4, Issue 2, 2003, Pages 53-56
|
Experimental study of the safety of the selective COX-2 inhibitor, celecoxib, for gastric mucosa
|
Author keywords
Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Gastric mucosal injuries; Nonsteroidal anti inflammatory drugs
|
Indexed keywords
6 OXOPROSTAGLANDIN F1 ALPHA;
ALCOHOL;
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
INDOMETACIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
THROMBOXANE B2;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DISEASE MODEL;
DISEASE SEVERITY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SELECTIVITY;
ENTERIC FEEDING;
ENZYME INHIBITION;
MALE;
MEDICAL ASSESSMENT;
MICROSCOPY;
MORPHOLOGY;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SCANNING ELECTRON MICROSCOPY;
STOMACH MUCOSA;
STOMACH MUCOSA LESION;
TISSUE NECROSIS;
|
EID: 0042566233
PISSN: 14439611
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1443-9573.2003.t01-1-00115.x Document Type: Article |
Times cited : (4)
|
References (7)
|